UnicoCell Biomed CoTPE:6794 83 Days Inventory is 232.83 as of Dec. 2025, which is 36% below its 10-year median of 366.01. GuruFocus rates TPE:6794 with a GF Score™ of 83/100 and a GF Value™ of NT$101.67 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 637 Biotechnology companies, UnicoCell Biomed Co ranks worse than 64.52% on this metric.
The historical rank and industry rank for UnicoCell Biomed Co's Days Inventory or its related term are showing as below:
TPE:6794'
s Days Inventory Range Over the Past 10 Years
Min: 213.51 Med: 366.01 Max: 923.59
Current: 265.86
During the past 9 years, UnicoCell Biomed Co's highest Days Inventory was 923.59. The lowest was 213.51. And the median was 366.01.
TPE:6794's Days Inventory is ranked worse than 64.52% of 637
companies
in the Biotechnology industry
Industry Median: 183.23
vs TPE:6794: 265.86
UnicoCell Biomed Co's Days Inventory
increased
from Dec. 2024 (190.41) to Dec. 2025 (232.83).
It might indicate that UnicoCell Biomed Co's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
UnicoCell Biomed Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.39.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
UnicoCell Biomed Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.31.
UnicoCell Biomed Co (TPE:6794) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
UnicoCell Biomed Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
UnicoCell Biomed Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
UnicoCell Biomed Co Days Inventory Related Terms
UnicoCell Biomed Co Days Inventory Historical Data
* Premium members only.
The historical data trend for UnicoCell Biomed Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6794 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, UnicoCell Biomed Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UnicoCell Biomed Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, UnicoCell Biomed Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where UnicoCell Biomed Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UnicoCell Biomed Co (TPE:6794) has a Days Inventory of 232.83 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on UnicoCell Biomed Co and its competitors. This is 36% below median its historical median of 366.01. Over the past decade, UnicoCell Biomed Co's Days Inventory has ranged from 213.51 to 923.59. According to the industry distribution chart, UnicoCell Biomed Co ranks #411 out of 637 companies in the Biotechnology industry, placing it in the top 64.5%.
Is UnicoCell Biomed Co's Days Inventory too high?
UnicoCell Biomed Co's current Days Inventory of 232.83 is 36% below median its 10-year median of 366.01. Over the past 10 years, this metric has ranged from a low of 213.51 to a high of 923.59. The Biotechnology industry median Days Inventory is 183.23. UnicoCell Biomed Co's value of 232.83 is 27.1% above this industry median. Based on the distribution chart, UnicoCell Biomed Co ranks #411 out of 637 companies in the Biotechnology industry, which is below the industry midpoint. Overall, UnicoCell Biomed Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnicoCell Biomed Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, UnicoCell Biomed Co ranks #411 out of 637 companies for Days Inventory. This places UnicoCell Biomed Co in the lower half of its industry. The industry median Days Inventory is 183.23. UnicoCell Biomed Co's value of 232.83 is 27.1% above this benchmark. Historically, UnicoCell Biomed Co's own Days Inventory has ranged from 213.51 to 923.59 over the past decade. While the company's 10-year median is 366.01 vs. the industry median of 183.23, UnicoCell Biomed Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UnicoCell Biomed Co's current Days Inventory of 232.83 is 27.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on UnicoCell Biomed Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UnicoCell Biomed Co's current Days Inventory is 232.83, which is 36% below median its own 10-year median of 366.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnicoCell Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, UnicoCell Biomed Co (TPE:6794) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$101.67, compared to a current price of NT$82.40 — trading 19% below its estimated fair value. The current Days Inventory is 232.83, which is 36% below median its 10-year median of 366.01 and 27.1% above the Biotechnology industry median of 183.23. UnicoCell Biomed Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For UnicoCell Biomed Co (TPE:6794), the current Days Inventory is 232.83 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UnicoCell Biomed Co (TPE:6794) Overvalued in 2026?
Based on GuruFocus' analysis, UnicoCell Biomed Co stock appears to be undervalued.
The current stock price of NT$82.40 is trading 19% below its estimated GF Value™ of NT$101.67.
GuruFocus considers UnicoCell Biomed Co to be Modestly Undervalued.
Key valuation signals for TPE:6794:
Days Inventory: 232.83 (36% below median its 10-year median of 366.01)
GF Value™: NT$101.67 vs. price of NT$82.40 (19% below fair value)
Industry Position: 27.1% above the Biotechnology median (#411 of 637)
No single metric tells the full story. See the TPE:6794 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UnicoCell Biomed Co Ltd is engaged in new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D. It focuses on researching and developing stem cells and its derived technology for medical applications, with the goal of advancing human health and improving quality of life. The company's products include Allogeneic Adipose Stem Cell Bank, Autologous Stem Cell Therapy, Conditioned Medium, Mass Production and CDMO, Cryogenic Vial (Class 2 Medical Device), and Testing services. It operates in single segment. Geographically, its operations are spread across Taiwan, Japan and Others with Taiwan generating the majority of the revenue.
83GF Score
Get the complete analysis for TPE:6794
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6794 has been successfully added to your 
